<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2228">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01211288</url>
  </required_header>
  <id_info>
    <org_study_id>F090730003</org_study_id>
    <nct_id>NCT01211288</nct_id>
  </id_info>
  <brief_title>Longitudinal Study of Dental Implant Therapy in HIV Positive Patients</brief_title>
  <official_title>Longitudinal Study of Dental Implant Therapy in HIV Positive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dentsply Sirona Implants</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to place implants in HIV positive and HIV negative patients then follow&#xD;
      patients over 3 years period of time to evaluate how well dental implants perform in HIV&#xD;
      positive patients versus HIV negative patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will review the osseointegration of implant supported restorations in HIV positive&#xD;
      and HIV negative patients, then follow patients over a 3 year period of time. The treatment&#xD;
      outcome as measured according to Mish criteria for implant success. Patients will be examined&#xD;
      at each interval for the presence of pain, infection, mobility, and radiographic bone height&#xD;
      of each implant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2010</start_date>
  <completion_date type="Actual">May 1, 2020</completion_date>
  <primary_completion_date type="Actual">April 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects</measure>
    <time_frame>Baseline to 12 months after implant restoration complete</time_frame>
    <description>Dental implant supported restorations functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects</measure>
    <time_frame>Baseline to 24 months after implant restoration complete</time_frame>
    <description>Dental Implant supported restoration functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects</measure>
    <time_frame>Baseline to 36 months after implant restoration complete</time_frame>
    <description>Dental implant supported restoration functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects</measure>
    <time_frame>12 months after implant restoration</time_frame>
    <description>Radiographic examination of implant osseointegration and bone loss by using traditional periapical and/or bitewing radiographs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects</measure>
    <time_frame>24 months after implant restoration</time_frame>
    <description>Radiographic examination of implant osseointegration and bone loss by using traditional periapical and/or bitewing radiographs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects</measure>
    <time_frame>36 months after implant restoration</time_frame>
    <description>Radiographic examination of implant osseointegration and bone loss by using traditional periapical and /or bitewing radiographs.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Dental Implant</condition>
  <arm_group>
    <arm_group_label>HIV negative group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group contains participants consented to receive implants and identified as negative for HIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV positive group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group contains participants consented to receive implants and identified as positive for HIV</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Astra implants</intervention_name>
    <description>Root form OsseoSpeed TX Astra Tech Implant System</description>
    <arm_group_label>HIV negative group</arm_group_label>
    <arm_group_label>HIV positive group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy enough to undergo the proposed therapy without compromise to existing health&#xD;
             status&#xD;
&#xD;
          -  At least 19 years old&#xD;
&#xD;
          -  Able to read and understand written English without the aid of ad hoc interpretation&#xD;
&#xD;
          -  Able to cognitively understand the proposed study and therapy and possible prognoses&#xD;
&#xD;
          -  Able to consent for their own inclusion in the study.&#xD;
&#xD;
          -  Implant supported restorations are limited to the following edentulous areas:&#xD;
             Mandibular arch (excluding 2nd and 3rd molar areas), Maxillary anterior and premolar&#xD;
             areas&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoker&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Bisphosphonate user&#xD;
&#xD;
          -  Bruxer&#xD;
&#xD;
          -  Extraction site healed less than 6 months&#xD;
&#xD;
          -  Women pregnant or lactating at the time of enrollment&#xD;
&#xD;
          -  Previous malignant neoplasm&#xD;
&#xD;
          -  A known hypersensitivity to Titanium metal&#xD;
&#xD;
          -  Any medication/condition that in the opinion of the clinical investigators may&#xD;
             adversely affect bone healing&#xD;
&#xD;
          -  Any indication of an inability to make autonomous decisions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toni T Neumeier, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UAB Dental School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UAB Dental School</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>September 28, 2010</study_first_submitted>
  <study_first_submitted_qc>September 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2010</study_first_posted>
  <results_first_submitted>May 1, 2020</results_first_submitted>
  <results_first_submitted_qc>May 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 15, 2020</results_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Toni Neumeier</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Implant</keyword>
  <keyword>Crown</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Seropositivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>To be determined</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 30, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/88/NCT01211288/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>HIV Negative Group</title>
          <description>This group contains participants consented to receive implants and identified as negative for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
        </group>
        <group group_id="P2">
          <title>HIV Positive Group</title>
          <description>This group contains participants consented to receive implants and identified as positive for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>HIV Negative Group</title>
          <description>This group contains participants consented to receive implants and identified as negative for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
        </group>
        <group group_id="B2">
          <title>HIV Positive Group</title>
          <description>This group contains participants consented to receive implants and identified as positive for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="41"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects</title>
        <description>Dental implant supported restorations functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.</description>
        <time_frame>Baseline to 12 months after implant restoration complete</time_frame>
        <population>Unable to do follow up on 3 participants - two participants from HIV negative group and one participant from HIV positive group, and one implant failure from HIV positive group</population>
        <group_list>
          <group group_id="O1">
            <title>HIV Negative Group</title>
            <description>This group contains participants consented to receive implants and identified as negative for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
          <group group_id="O2">
            <title>HIV Positive Group</title>
            <description>This group contains participants consented to receive implants and identified as positive for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects</title>
          <description>Dental implant supported restorations functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.</description>
          <population>Unable to do follow up on 3 participants - two participants from HIV negative group and one participant from HIV positive group, and one implant failure from HIV positive group</population>
          <units>implants</units>
          <param>Number</param>
          <units_analyzed>implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects</title>
        <description>Dental Implant supported restoration functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.</description>
        <time_frame>Baseline to 24 months after implant restoration complete</time_frame>
        <population>Unable to do follow up on 7 participants, three participants from HIV negative group and four participants from HIV positive group</population>
        <group_list>
          <group group_id="O1">
            <title>HIV Negative Group</title>
            <description>This group contains participants consented to receive implants and identified as negative for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
          <group group_id="O2">
            <title>HIV Positive Group</title>
            <description>This group contains participants consented to receive implants and identified as positive for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects</title>
          <description>Dental Implant supported restoration functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.</description>
          <population>Unable to do follow up on 7 participants, three participants from HIV negative group and four participants from HIV positive group</population>
          <units>implants</units>
          <param>Number</param>
          <units_analyzed>implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects</title>
        <description>Dental implant supported restoration functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.</description>
        <time_frame>Baseline to 36 months after implant restoration complete</time_frame>
        <population>Unable to do follow up on 11 participants, five participants from HIV negative group and six participants from HIV positive group</population>
        <group_list>
          <group group_id="O1">
            <title>HIV Negative Group</title>
            <description>This group contains participants consented to receive implants and identified as negative for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
          <group group_id="O2">
            <title>HIV Positive Group</title>
            <description>This group contains participants consented to receive implants and identified as positive for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects</title>
          <description>Dental implant supported restoration functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.</description>
          <population>Unable to do follow up on 11 participants, five participants from HIV negative group and six participants from HIV positive group</population>
          <units>implants</units>
          <param>Number</param>
          <units_analyzed>implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects</title>
        <description>Radiographic examination of implant osseointegration and bone loss by using traditional periapical and/or bitewing radiographs.</description>
        <time_frame>12 months after implant restoration</time_frame>
        <population>Unable to do follow up on three participants, two from HIV negative group and one from HIV positive group</population>
        <group_list>
          <group group_id="O1">
            <title>HIV Negative Group</title>
            <description>This group contains participants consented to receive implants and identified as negative for HIV. Some participants has more than one implant.&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
          <group group_id="O2">
            <title>HIV Positive Group</title>
            <description>This group contains participants consented to receive implants and identified as positive for HIV.Some participants has more than one implant.&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
        </group_list>
        <measure>
          <title>Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects</title>
          <description>Radiographic examination of implant osseointegration and bone loss by using traditional periapical and/or bitewing radiographs.</description>
          <population>Unable to do follow up on three participants, two from HIV negative group and one from HIV positive group</population>
          <units>millmeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.58"/>
                    <measurement group_id="O2" value="0.35" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects</title>
        <description>Radiographic examination of implant osseointegration and bone loss by using traditional periapical and/or bitewing radiographs.</description>
        <time_frame>24 months after implant restoration</time_frame>
        <population>Unable to do follow up on 7 participants, three from HIV negative group and four from HIV positive group</population>
        <group_list>
          <group group_id="O1">
            <title>HIV Negative Group</title>
            <description>This group contains participants consented to receive implants and identified as negative for HIV. Some participants has more than one implant.&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
          <group group_id="O2">
            <title>HIV Positive Group</title>
            <description>This group contains participants consented to receive implants and identified as positive for HIV.Some participants has more than one implant.&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
        </group_list>
        <measure>
          <title>Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects</title>
          <description>Radiographic examination of implant osseointegration and bone loss by using traditional periapical and/or bitewing radiographs.</description>
          <population>Unable to do follow up on 7 participants, three from HIV negative group and four from HIV positive group</population>
          <units>millmeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" spread="0.49"/>
                    <measurement group_id="O2" value="0.33" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects</title>
        <description>Radiographic examination of implant osseointegration and bone loss by using traditional periapical and /or bitewing radiographs.</description>
        <time_frame>36 months after implant restoration</time_frame>
        <population>Unable to do follow up on 11 participants, five from HIV negative group and six from HIV positive group</population>
        <group_list>
          <group group_id="O1">
            <title>HIV Negative Group</title>
            <description>This group contains participants consented to receive implants and identified as negative for HIV. Some participants has more than one implant.&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
          <group group_id="O2">
            <title>HIV Positive Group</title>
            <description>This group contains participants consented to receive implants and identified as positive for HIV.Some participants has more than one implant.&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
          </group>
        </group_list>
        <measure>
          <title>Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects</title>
          <description>Radiographic examination of implant osseointegration and bone loss by using traditional periapical and /or bitewing radiographs.</description>
          <population>Unable to do follow up on 11 participants, five from HIV negative group and six from HIV positive group</population>
          <units>millmeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="0.52"/>
                    <measurement group_id="O2" value="0.48" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The specific period for this study was over 8 years from the time the first subject selected until 3 years follow up completed.</time_frame>
      <desc>Total 11 participants did not complete all follow up appointments through the end of the study. There are 5 in HIV negative group and 6 in HIV positive group.</desc>
      <group_list>
        <group group_id="E1">
          <title>HIV Negative Group</title>
          <description>This group contains participants consented to receive implants and identified as negative for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
        </group>
        <group group_id="E2">
          <title>HIV Positive Group</title>
          <description>This group contains participants consented to receive implants and identified as positive for HIV&#xD;
Astra implants: Root form OsseoSpeed TX Astra Tech Implant System</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Based on a survey given every year, participants were extremely satisfied with the outcome.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Toni Tien Neumeier</name_or_title>
      <organization>University of Alabama at Birmingham</organization>
      <phone>205-934-5459</phone>
      <email>neumeier@uab.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

